CD19 and myasthenia gravis: As we detected a significant overexpression of miR-150 in patients with a high degree of thymic hyperplasia, we analyzed the expression of CD19 mRNA, a B-cell marker, in correlation with miR-150 expression for controls and untreated-MG patients.